Overcome the first cervical cancer vaccine

Cervical cancer vaccine, "Jia Dexi" has become the world's first cancer prevention vaccine, this vaccine is likely to be allowed to market this year, the future may be in the world to eliminate cervical cancer, while at the same time, medical experts are is committed to research and development of vaccines against other types of cancer. Some experts said the capture of human cancer from the day drawing near.

Worldwide, cervical cancer is the second cause of death in women, cancer killer, with 50 million people diagnosed each year, about 30 million people died. By the "human papilloma virus" (HPV) are two subtypes lead to cervical cancer accounted for 70% of the total, but the scientists have successfully developed a vaccine can be 100% so that these two types of the body from infection of HPV.

U.S. media reported that the success of this new vaccine has historic significance, humans finally have the opportunity to be a total eradication of cancer. This year in June, the U.S. Food and Drug Administration (FDA) on this vaccine will be reviewed to decide whether to approve the vaccine in the U.S.. The vaccine developed by the German pharmaceutical company Merck & Co., called "Jia Dexi."

Anti-cancer vaccine to the human body

The immune system "rejuvenating"

In the meantime, for other types of cancer vaccines under development, which. Now, a treatment for prostate cancer vaccines have been developed, and become the life-extension of prostate cancer patients the best treatment. Although some experts believe that the scope of clinical trials of this vaccine is too small, but the pharmaceutical companies have submitted applications for FDA.

The common denominator is that these vaccines are to make the body's immune system, "rejuvenated" and restore vitality, ready to eliminate fatal harm to the body mortal enemy.

According to reports, HPV through sexual transmission, 25% of teenagers and young men and women may be infected with the virus at any time. However, in most people, HPV infection can go away. However, a few cases, certain high-risk types of HPV, if not detected and treatment can lead to cervical cancer.

HPV in the body as "latency." U.S. cervical cancer expert Daianhapo Dartmouth Medical School, said that is why in his early juvenile period and 20 age groups are infected with HPV virus, the peak period, but the next is the 30-year-old female suffering from cervical cancer-prone period.

     It is understood that cervical cancer vaccines need to kick down the 3-pin within six months, after which the body's ability to resist HPV is hundreds of times higher than normal. The study also showed that vaccinated people can at least three and a half years to maintain this status. University of Washington epidemiologist Laura Tesi Ji-led research team injected 6000, "Jia Dexi" vaccine to conduct follow-up survey of women found that after 17 months they can still be on the HPV immunization; while 6000 has not injected, "Jia Dexi" in women, 21 were pathological changes occurred, some of which were likely to develop symptoms of cancer.